ARCHIVES

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

To Review Cancer Bioinformatics Grid

November 12, 2010

DCT Advisers Ok Expansion of Phase 1, Phase 2 Testing

July 10, 1992

NCAB Delays Decision On Organ Site Program Until May Meeting

February 12, 1982

In Brief: Carcinogenesis Task Force to Wrap Up Review In Four-Six Weeks; UCLA Groundbreaking Set

October 28, 1977

NIH Defends NCI Sponsored Travel

December 3, 2010

In Brief: Senate Committee Refuses to Cut NCI 1982 Funds; Linus Pauling to Speak At conference On Vitamins

November 13, 1981